Adage Capital Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.42M | Buy |
463,600
+442,400
| +2,087% | +$7.08M | 0.01% | 665 |
|
|
2025
Q1 | $362K | Sell |
21,200
-278,800
| -93% | -$4.76M | ﹤0.01% | 816 |
|
|
2024
Q4 | $7.43M | Hold |
300,000
| – | – | 0.01% | 664 |
|
|
2024
Q3 | $8.55M | Sell |
300,000
-120,000
| -29% | -$3.42M | 0.02% | 640 |
|
|
2024
Q2 | $11.1M | Buy |
420,000
+320,000
| +320% | +$8.45M | 0.02% | 579 |
|
|
2024
Q1 | $3.23M | Sell |
100,000
-1,231,780
| -92% | -$39.8M | 0.01% | 739 |
|
|
2023
Q4 | $56.1M | Buy |
1,331,780
+897,280
| +207% | +$37.8M | 0.12% | 187 |
|
|
2023
Q3 | $16.7M | Buy |
+434,500
| New | +$16.7M | 0.04% | 441 |
|
|
2021
Q1 | – | Sell |
-1,400,851
| Closed | -$64.7M | – | 985 |
|
|
2020
Q4 | $64.7M | Buy |
1,400,851
+95,851
| +7% | +$4.43M | 0.14% | 162 |
|
|
2020
Q3 | $45.9M | Sell |
1,305,000
-1,061,062
| -45% | -$37.3M | 0.12% | 191 |
|
|
2020
Q2 | $57.6M | Buy |
2,366,062
+1,346,062
| +132% | +$32.8M | 0.15% | 160 |
|
|
2020
Q1 | $15.9M | Hold |
1,020,000
| – | – | 0.05% | 375 |
|
|
2019
Q4 | $16.2M | Buy |
+1,020,000
| New | +$16.2M | 0.04% | 423 |
|